Page 5 - Presentation

The Radioligand Therapy Revolution in Prostate Cancer: Is Canada Ready?

Lutetium-177-PSMA-617 for Prostate Cancer:

Current Evidence for Future Practice

Medical Oncologist, Vancouver Cancer Centre and Vancouver Prostate Centre

Chief Medical Officer, BC Cancer

Professor, Faculty of Medicine, University of British Columbia

Professor, Faculty of Health Sciences, Simon Fraser University

Shrum Chair in Prostate Cancer Research